We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Hartford MidCap HLS IB Fund (HBMCX) in Focus
Hartford MidCap HLS IB (HBMCX - Free Report) a Zacks Rank #2 (Buy) seeks long-term growth of capital. HBMCX invests the majority of its assets in common stocks of mid-capitalization companies. HBMCX may invest up to 20% of its net assets in securities of foreign issuers and non-dollar securities.
This Mid Blend fund, as of the last filing, allocates their fund in three major groups; Small Growth, Large Growth and Large Value. Further, as of the last filing, GENPACT LTD, TRANSUNION and VERISIGN INC, Inc were the top holdings for HBMCX.
The Hartford MidCap HLS IB fund, managed by Hartford, carries an expense ratio of 0.96%.
HBMCX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3, 5 year benchmarks; 1 year 19.29%, 3 year 10.55% and 5 year 16.15%. To see how this fund performed compared in its category and other #1 and #2 Ranked Mutual Funds, please click here.
HBMCX,’s performance, as of the last filing, when compared to funds in its category was in the top 15% in 1 year, top 21% over the past 3 years, and in the 8% over the past 5 years.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>